Nivolumab,Ipilimumab
BMS
['nivo', 'niche-2']
#esmo22 presidential symposium ii highlights:
niche-2 (lba7) - neoadjuvant ici (1 cycle nivo+ipi, 1 cycle nivo) in la dmmr colon cancer (n=112) remarkable pcr rate of 95% w/ 4wks tx. "this....is a waterfall plot." &lt;audience applause&gt; only 4% g3/4 iraes 
CME experts Sara Fagerlie, PhD, CHCP & Mindy Tanzola, PhD have joined forces at Front Row to help clinicians & educators manage the oncology information deluge